Press Release - Commcise and Sloane Robinson roll-out research evaluation platform

Delivering comprehensive cross-team research evaluation solution

London, New York, 9th May 2018. Commcise, the award-winning provider of fully integrated end-to-end commission management, research evaluation and reporting solutions for investment management firms, is delighted to announce the on-going deployment of its CommciseBUY research valuation platform at Sloane Robinson, an International long/short equity manager with a particular focus on the Asian, Emerging and Frontier markets.

The Commcise functionality used by Sloane Robinson includes research budgeting and valuation; broker voting and payments; internal reporting including fund-level research cost allocation.  The implementation was undertaken by a joint Commcise and Sloane Robinson team, including integration with Sloane Robinson systems.

David Gale, CEO at Sloane Robinson, said: “Sloane Robinson chose Commcise after a careful selection process, which was focused on ensuring we would meet our internal standards on research transparency.  As an asset manager that utilises research services across the globe, we required a solution that would be both seamless to deploy but provided a consistency in data presentation and evaluation protocol.  Commcise was selected as it best matched these requirements.  People matter, and we have found the Commcise team extremely professional and diligent throughout the design and implementation phases of this project.”

Paul Charie, Commcise Global Head of Sales commented: “We were delighted to add Sloane Robinson to the fast-growing list of clients already using Commcise around the globe.  Sloane Robinson input into the developments of the CommciseBUY platform to support the new world of research valuation has been extremely useful.  We look forward to continuing to build a long-term business relationship with Sloane Robinson as our industry evolves in the coming years.”

* END *

For more information contact:
Melanie Budden
The Realization Group
+44 (0)7974 937970

About Commcise

Commcise offers independent, fully-integrated commission management solutions to the buy-side, sell-side and research providers. Commcise Buy, our award-winning cloud-based commission management platform is designed from the ground up to meet the specific needs of investment managers. Commcise Buy is the market-leading software solution helping asset managers to evidence end-to-end compliance with the latest MiFID II regulatory requirements. Commcise Buy provides automated trade reconciliation, algorithmic rules engine, invoice management, research evaluation / broker vote, consumption tracking (including an automated research valuation engine), commission budgeting, research accounting and reporting in a single fully-audited solution.

Commcise was founded by buy side industry professionals, with founding members including the partners of a leading Investment Technology consulting firm who have in-depth experience of implementing complex global technology solutions for asset management firms. With over 200 buy-side and sell-side clients globally, Commcise’s clients include some of the largest institutional asset managers, hedge funds and brokers in the world.

For further information on Commcise, please go to or follow us on Twitter at @commcise

About Sloane Robinson

Sloane Robinson is a boutique asset manager founded in 1993 who today manages US$1.6bn in the international equity markets (with a particular bias towards the more emerging markets). They operate out of a single location in London, and follow a long/short equity, market directional approach to investing, with a core competence in stock selection. Macro matters and often guides the research analysis away from the more impaired markets and towards structurally supportive environments. The micro analysis then follows and seeks to identify companies that meet the necessary criteria for ownership as either a Compounder, Dynamic Change or Deep Value opportunity. All portfolios are benchmark unconstrained and concentration of positons is favoured, with typically 30-35 long investments held.

For further information on Sloane Robinson, please contact

Share this article